Ambrose Agweyu/BMC Infect Dis
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano D
Kutima B
Kimani M
Sigilai A
Gitonga J
Karani A
Akech D
Karia B
Ziraba AK
Maina A
Lambisia A
Omuoyo D
Mugo D
Lucinde R
Owuor S
Konyino G
Newman J
Bailey D
Nduati E
Githinji G
Agoti CN
Bejon P
Scott JAG
Agweyu A
Kagucia W
Warimwe GM
Sande C
Ochola-Oyier LI
Nyagwange J
BMC Infect Dis, (2024). 24:1474
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.Lucinde RK
Gathuri H
Isaaka L
Ogero M
Mumelo L
Kimego D
Mbevi G
Wanyama C
Otieno EO
Mwakio S
Saisi M
Isinde E
Oginga IN
Wachira A
Manuthu E
Kariuki H
Nyikuli J
Wekesa C
Otedo A
Bosire H
Okoth SB
Ongalo W
Mukabi D
Lusamba W
Muthui B
Adembesa I
Mithi C
Sood M
Ahmed N
Gituma B
Giabe M
Omondi C
Aman R
Amoth P
Kasera K
Were F
Nganga W
Berkley JA
Tsofa B
Mwangangi J
Bejon P
Barasa E
English M
Scott JAG
Akech S
Kagucia EW
Agweyu A
Etyang AO
BMC Infect Dis, (2024). 24:1246
